Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Abstract
Increased generation of reactive oxygen species (ROS) and an altered redox status have long been observed in cancer cells, and recent studies suggest that this biochemical property of cancer cells can be exploited for therapeutic benefits. Cancer cells in advanced stage tumours frequently exhibit multiple genetic alterations and high oxidative stress, suggesting that it might be possible to preferentially eliminate these cells by pharmacological ROS insults. However, the upregulation of antioxidant capacity in adaptation to intrinsic oxidative stress in cancer cells can confer drug resistance. Abrogation of such drug-resistant mechanisms by redox modulation could have significant therapeutic implications. We argue that modulating the unique redox regulatory mechanisms of cancer cells might be an effective strategy to eliminate these cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, available data suggest that MGF-driven restoration of redox homeostasis represents a central mechanistic axis of its antitumor activity, rather than merely a downstream branch of apoptosis (84,85).”
From Mangiferin in human disease: Multifaceted mechanisms and applications (Review) (2026) · cites this paper as [84]
In the citing paper
“Activation of oncogenes, aberrant metabolism, mitochondrial dysfunction, and loss of the tumor suppressor p53 can all promote increased ROS accumulation in cancer cells 69.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [69]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379 · cited 1×
“It has been observed that a small subpopulation of primary cancer cells expressing stem-cell markers was resistant to certain chemotherapeutic agents and radiatio”
BackgroundSchafer, F. Q., & Buettner, G. R. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00480-4 · Cited by 4,587 · cited 1×
“A moderate increase in ROS can promote cell proliferation and differentiatio”
BackgroundFive-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Druker, B. J., Guilhot, F., O'Brien, S. G., Gathmann, I., Kantarjian, H., Gattermann, N., Deininger, M. W. N., Silver, R. T., Goldman, J. M., Stone, R. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062867 · Cited by 3,488 · cited 1×
“By exploiting the genetic differences between normal cells and cancer cells, several molecular-targeted drugs, such as imatinib (Gleevec; Novartis) and trastuzumab (Herceptin; Genentech/Roche), show promising therapeutic activity and few toxic side effect”
BackgroundCancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2499 · Cited by 3,429 · cited 1×
“Redox status in cancer stem cells Recurrence of cancer after chemotherapy or radiotherapy is initiated by a subpopulation of residual malignant cells that are highly resistant to treatment and which are believed to be cancer-initiating cells or cancer stem cell”
Background(2012) · Hepatogastroenterology · doi:10.5754/hge12469 · Cited by 3,178
Production of large amounts of hydrogen peroxide by human tumor cells.
Szatrowski, T. P., & Nathan, C. (1991) · PubMed · Cited by 3,007
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555 · cited 1×
“Recent studies showed that normal haemopoietic stem cells and normal mammary epithelial stem cells maintained ROS at lower levels than their mature progeny to prevent cellular differentiation and maintain long-term self-renewa”
BackgroundBjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2007) · JAMA · doi:10.1001/jama.297.8.842 · Cited by 2,275
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272 · cited 1×
“This is consistent with the high incidence of p53 mutation or loss of p53 function in over 50% of human cancer”
Background
Research works printed but not linked: 1
- Kim, G. J., Chandrasekaran, K. & Morgan, W. F. Mitochondrial dysfunction, persistently elevated levels of reactive oxygen species and radiation-induced genomic instability: a review. Mutagenesis 21, 361–367 (2006). · DOI · Paper page
Cited by
Items 901–1,000 of 1,014
Daga, M., Ullio, C., Argenziano, M., Dianzani, C., Cavalli, R., Trotta, F., Ferretti, C., Zara, G. P., Gigliotti, C. L., Ciamporcero, E. S., et al. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.05.009 · Cited by 96
“This redox adaptation provides a mechanism of resistance to many anticancer agents, due to increased tolerance of exogenous stress and increased capacity for drug inactivation [6].”
Zhao, Y., Huo, D., Bao, J., Yang, M. J., Chen, M., Hou, J., Fa, H., & Hou, C. (2017) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2017.01.029 · Cited by 88
Benito, A., Polat, I. H., Noé, V., Ciudad, C. J., Marín, S., & Cascante, M. (2017) · Oncotarget · doi:10.18632/oncotarget.21601 · Cited by 94
“It is widely accepted that most tumors deal with increased levels of ROS, leading to intracellular conditions of high oxidative stress [18, 38].”
BackgroundHassani, S., Ghaffari, P., Chahardouli, B., Alimoghaddam, K., Ghavamzadeh, A., Alizadeh, S., & Ghaffari, S. H. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.109 · Cited by 88
Fernando, W., Rupasinghe, H. P. V., & Hoskin, D. W. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.022 · Cited by 90
Programmable ROS‐Mediated Cancer Therapy via Magneto‐Inductions
Wu, J., Ning, P., Gao, R., Feng, Q., Shen, Y., Zhang, Y., Li, Y., Xu, C., Qin, Y., Plaza, G. R., et al. (2020) · Advanced Science · doi:10.1002/advs.201902933 · Cited by 89
Cyclodextrin-based delivery systems for in vivo-tested anticancer therapies
Paiva‐Santos, A. C., Costa, D., Ferreira, L., Guerra, C., Pereira‐Silva, M., Pereira, I., Peixoto, D., Ferreira, N. R., & Veiga, F. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00778-5 · Cited by 91
Sang, J., Li, W., Diao, H., Fan, R., Huang, J.-L., Gan, L., Zou, M.-F., Tang, G., & Yin, S. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.03.030 · Cited by 93
Recent advancements in bioadhesive self-healing hydrogels for effective chronic wound care
Nezhad‐Mokhtari, P., Hasany, M., Kohestanian, M., Dolatshahi‐Pirouz, A., Milani, M., & Mehrali, M. (2024) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2024.103306 · Cited by 94
Glorieux, C., & Calderón, P. B. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103404 · Cited by 96
“Owing to their high intrinsic oxidative stress, cancer cells are more vulnerable to ROS-mediated damage and ROS-based therapeutic strategies have shown promising anticancer activity [128,129].”
BackgroundNanogels: A chemically versatile drug delivery platform
Blagojevic, L., & Kamaly, N. (2025) · Nano Today · doi:10.1016/j.nantod.2025.102645 · Cited by 94
Li, T., Zhu, J., Guo, L. C., Shi, X., Liu, Y., & Yang, X. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2013.04.050 · Cited by 88
Modulation of Hydrogen Peroxide Production in Cellular Systems by Low Level Magnetic Fields
Martino, C. F., & Castello, P. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022753 · Cited by 93
Is Reliance on Mitochondrial Respiration a “Chink in the Armor” of Therapy-Resistant Cancer?
Wolf, D. A. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.001 · Cited by 85
“This ‘‘threshold concept’’ of ROS activity and the preferential sensitivity of cancer cells toward apoptosis induced by high levels of ROS is now widely established and provides a solid basis for cancer selectivity of mitochondrial inhibitors (reviewed in Kong et al., 2000; Luo et al., 2009; Trachootham et al., 2009;…”
BackgroundROS‐Inducible DNA Cross‐Linking Agent as a New Anticancer Prodrug Building Block
Cao, S., Wang, Y., & Peng, X. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201200075 · Cited by 95
Liu, J., Bo, X., Yang, J. Z., Yin, D., & Guo, L. (2017) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2017.03.117 · Cited by 87
Wu, S., Liu, G., Zhou, S., Sha, Z., & Sun, C. (2019) · Marine Drugs · doi:10.3390/md17040199 · Cited by 94
“High concentrations of ROS are harmful to cells and result in cell death [30,31].”
BackgroundAn, H., Guo, C., Li, D., Liu, R., Xu, X., Guo, J., Ding, J., Li, J., Chen, W., & Zhang, J. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c01413 · Cited by 86
Redox regulation of tumor suppressor PTEN in cell signaling
Zhang, Y., Park, J., Han, S.-J., Yang, S. Y., Yoon, H. J., Park, I., Woo, H. A., & Lee, S.-R. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101553 · Cited by 92
Copper(II) N,N,O-Chelating Complexes as Potential Anticancer Agents
Peña, Q., Sciortino, G., Maréchal, J., Bertaina, S., Simaan, A. J., Lorenzo, J., Capdevila, M., Bayón, P., Iranzo, O., & Palacios, Ò. (2021) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.0c02932 · Cited by 93
Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics
Ang, M. J. Y., Chan, S. Y., Goh, Y. Y., Luo, Z., Lau, J. W., & Liu, X. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113907 · Cited by 91
Dual Role of Plant Phenolic Compounds as Antioxidants and Prooxidants
Rajashekar, C. B. (2023) · American Journal of Plant Sciences · doi:10.4236/ajps.2023.141002 · Cited by 99
Nanomaterial-based regulation of redox metabolism for enhancing cancer therapy
Jia, X., Wang, Y., Qiao, Y., Jiang, X., & Li, J. (2024) · Chemical Society Reviews · doi:10.1039/d4cs00404c · Cited by 91
Mitochondrial dysfunction in cancer chemoresistance
Guaragnella, N., Giannattasio, S., & Moro, L. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.027 · Cited by 90
“redox regulation in the development of resistance to ROS-inducing drugs, cancer cell insensitivity to the chemotherapeutic drugs paclitaxel and cisplatin has been associated with increased antioxidant expression levels [91-93].”
Yang, W., Shen, Y., Wei, J., & Liu, F. (2015) · Oncotarget · doi:10.18632/oncotarget.4292 · Cited by 97
Liu, X., Cao, R., Wang, S., Jia, J., & Hao, F. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b02016 · Cited by 87
Ishimoto, T., Sugihara, H., Watanabe, M., Sawayama, H., Iwatsuki, M., Baba, Y., Okabe, H., Hidaka, K., Yokoyama, N., Miyake, K., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt402 · Cited by 86
“Redox adaptation not only enables cancer cells to survive under increased ROS stress but also renders them resistant to certain anticancer drugs (28,29).”
BackgroundDissecting the role of redox signaling in neuronal development
Bórquez, D. A., Urrutia, P. J., Wilson, C., van Zundert, B., Núñez, M. T., & González‐Billault, C. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13581 · Cited by 86
“…been canonically described as toxic by-products of aerobic cellular energy metabolism and are associated with the onset of several diseases, particularly those related to aging such as cancer, neurodegenerative diseases, and diabetes (Andersen 2004; Trachootham et al. 2009; Sohal and Orr 2012).”
BackgroundWang, W., Liang, G., Zhang, W., Xing, D., & Hu, X. (2018) · Chemistry of Materials · doi:10.1021/acs.chemmater.8b01149 · Cited by 88
Bi, Z., Li, Q., Dinglin, X.-X., Xu, Y. X., You, K., Hong, H., Hu, Q., Zhang, W., Li, C., Tan, Y., et al. (2020) · Advanced Science · doi:10.1002/advs.202000915 · Cited by 102
Anticancer boron-containing prodrugs responsive to oxidative stress from the tumor microenvironment
Maslah, H., Skarbek, C., Pèthe, S., & Labruère, R. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112670 · Cited by 87
Fe3O4@Pt nanoparticles to enable combinational electrodynamic/chemodynamic therapy
Chen, T., Chu, Q., Li, M., Han, G., & Li, X. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00957-7 · Cited by 86
“However, excessive intracellular ROS induces the damage of proteins, lipids and DNA with no specificallity [4, 5], and thus cancer therapies based on ROS have been extenstively explored in the past years [6–10].”
BackgroundEndogenous Copper for Nanocatalytic Oxidative Damage and Self-Protection Pathway Breakage of Cancer
Guo, Y., Xu, Y., Bao, Q., Shen, C., Ni, D., Hu, P., & Shi, J. (2021) · ACS Nano · doi:10.1021/acsnano.1c05451 · Cited by 87
Pan, S., Li, T., Tan, Y., & Xu, H. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121321 · Cited by 87
Zhang, X., Chen, M., Zou, P., Kanchana, K., Weng, Q., Chen, W., Zhong, P., Ji, J., Zhou, H., He, L., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1851-3 · Cited by 86
“Increased ROS generation and oxidative stress have been reported in prostate cancer cells [11].”
BackgroundVinothkumar, R., Rajamanickam, V., Sudha, M., & Nalini, N. (2013) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e32836473ac · Cited by 87
“Trachootham et al. (2009) have suggested that if the levels of ROS are altered by GSH modulation, it is the way to kill cancer cells without causing significant toxicity to normal cells.”
BackgroundDuan, J., Lu, X., & He, G. (2017) · Journal of Applied Physics · doi:10.1063/1.4973484 · Cited by 86
Chen, P., Luo, X., Nie, P., Wu, B., Xu, W. G., Shi, X., Chang, H., Li, B., Yu, X., & Zou, Z. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.033 · Cited by 89
Gunasekaran, V., Elangovan, K., & Devaraj, S. N. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.03.029 · Cited by 89
“…many drugs showed extensive chemotherapeutic potential in preclinical models, by modulating the redox signature of the cancer cells, they failed to be a better alternative, due to their wash out by the intrinsic antioxidant defense system M AN US CR IP T AC CE PT ED 15 (Trachootham et al., 2009).”
BackgroundCationic micelle: A promising nanocarrier for gene delivery with high transfection efficiency
Wang, H., Ding, S., Zhang, Z., Wang, L., & You, Y. (2019) · The Journal of Gene Medicine · doi:10.1002/jgm.3101 · Cited by 86
Self-assembly of oxidation-responsive polyethylene glycol-paclitaxel prodrug for cancer chemotherapy
Dong, C., Zhou, Q., Xiang, J., Liu, F., Zhou, Z., & Shen, Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.038 · Cited by 85
Erdélyi, K., Ditrói, T., Johansson, H. J., Czikora, Á., Balog, N., Silwal‐Pandit, L., Ida, T., Olasz, J., Hajdú, D., Mátrai, Z., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100050118 · Cited by 91
Applications of Plasma-Activated Liquid in the Medical Field
Kim, S., & Kim, C. (2021) · Biomedicines · doi:10.3390/biomedicines9111700 · Cited by 93
“When ROS flows into cancer cells with elevated intracellular ROS levels due to metabolic abnormalities, the intracellular ROS level of cancer cell reaches the toxicity threshold more easily than in normal cells [84].”
BackgroundHigh-Dose Vitamin C for Cancer Therapy
Mussa, A., Idris, R. A. M., Ahmed, N., Ahmad, S., Murtadha, A. H., Din, T. A. D. A. T., Yean, C. Y., Rahman, W. F. W. A., Lazim, N. M., Uskoković, V., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15060711 · Cited by 91
“Cells use a range of mechanisms to counteract ROS-induced oxidative stress, all of which are mediated by different antioxidant regulatory systems, including CAT, superoxide dismutases (SODs), glutathione peroxidases (GPXs), and Peroxiredoxins (PRDXs) [63,202,203].”
BackgroundProtein tyrosine phosphatase structure–function relationships in regulation and pathogenesis
Böhmer, F., Szedlacsek, S. E., Tabernero, L., Östman, A., & den Hertog, J. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08655.x · Cited by 102
Ni, Z., Wang, B., Dai, X., Ding, W., Yang, T., Li, X., Lewin, S. J., Xu, L., Lian, J., & He, F. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.02.012 · Cited by 87
Strathmann, J., Klimo, K., Sauer, S. W., Okun, J. G., Prehn, J. H. M., & Gerhäuser, C. (2010) · The FASEB Journal · doi:10.1096/fj.10-155846 · Cited by 95
“, TP53), altered metabolism, and mitochondrial functions (15).”
BackgroundMetere, A., Frezzotti, F., Graves, C. E., Vergine, M., Luca, A. D., Pietraforte, D., & Giacomelli, L. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0504-4 · Cited by 86
Protein Acyltransferase DHHC3 Regulates Breast Tumor Growth, Oxidative Stress, and Senescence
Sharma, C., Wang, H.-X., Li, Q., Knoblich, K., Reisenbichler, E., Richardson, A. L., & Hemler, M. E. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1536 · Cited by 87
Oxidative stress promotes exit from the stem cell state and spontaneous neuronal differentiation
Hu, Q., Khanna, P., Wong, B. S. E., Heng, Z. S., Subhramanyam, C. S., Thanga, L. Z., Tan, S. W. S., & Baeg, G. H. (2017) · Oncotarget · doi:10.18632/oncotarget.23786 · Cited by 88
“Low-to-moderate steadystate levels of ROS are known to be essential for cellular proliferation, differentiation, and survival [5].”
BackgroundGreenshields, A. L., Fernando, W., & Hoskin, D. W. (2019) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2019.01.006 · Cited by 86
Selective Anticancer Therapy Using Pro-Oxidant Drug-Loaded Chitosan–Fucoidan Nanoparticles
Choi, D. G., Venkatesan, J., & Shim, M. S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133220 · Cited by 87
“Recently, pro-oxidant cancer therapy that can selectively kill cancer cells by the generation of cytotoxic oxidative stress in cancer cells has emerged as an effective strategy for cancer-specific treatments [12,13].”
BackgroundResultTargeting Reactive Oxygen Species in Cancer via Chinese Herbal Medicine
Qian, Q., Chen, W., Cao, Y., Cao, Q., Cui, Y., Li, Y., & Wu, J. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9240426 · Cited by 90
“In addition, ROS are involved in the antitumor activity of many chemotherapeutic agents, small molecular targeted drugs, and radiation therapy, as well as their side effects [105, 106].”
BackgroundChen, M., Zhu, J., Mu, W.-J., & Guo, L. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2021.12.023 · Cited by 95
“Enhanced antioxidative capacity not only allows cancer cells to survive under oxidative stress and to facilitate cancer cell transformation and metastasis,(90) but also leads to resistance to ROS-generating agents.(91) Therefore, the silencing of CDO1 may enhance the detoxification of ROS and enhance the survival of c…”
BackgroundDynamic assembly of DNA-ceria nanocomplex in living cells generates artificial peroxisome
Yao, C., Xu, Y., Tang, J., Hu, P., Qi, H., & Yang, D. (2022) · Nature Communications · doi:10.1038/s41467-022-35472-2 · Cited by 89
Fitzgerald, A. L., Osman, A. A., Xie, T.-X., Patel, A., Skinner, H., Sandulache, V, & Myers, J. N. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.44 · Cited by 83
Song, C., Ji, R., Du, F., & Li, Z. (2013) · Macromolecules · doi:10.1021/ma401656t · Cited by 90
Leung, E. L., Fan, X., Wong, M. P., Jiang, Z., Liu, Z., Yao, X., Lu, L., Zhou, Y., Yau, L.-F., Tin, V. P., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6420 · Cited by 88
“Although the precise mechanism of resistance remains unclear, reactive oxygen species (ROS) are heavily involved in cancer initiation and regulation by low-dose environmental pollutants (16), while the modulation of oxidative stress is recently proposed as a promising strategy for cancer therapy (17, 55).”
BackgroundTargeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer
Roh, J., Jang, H.-J., Kim, E. H., & Shin, D. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6841 · Cited by 88
“The persistent oxidative stress in cancer partly explains why cancer cells have characteristics that differ from those of normal cells, which are more vulnerable to damage by further ROS insults (31).”
Dioscin Induces Gallbladder Cancer Apoptosis by Inhibiting ROS-Mediated PI3K/AKT Signalling
Song, X., Wang, Z., Liang, H., Zhang, W., Ye, Y., Li, H., Hu, Y., Zhang, Y., Weng, H., Lu, J., et al. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.18732 · Cited by 84
“profound effect on cell survival and drug sensitivity by altering the ability of cells to detoxify ROS [15].”
BackgroundActivatable Singlet Oxygen Generation from Lipid Hydroperoxide Nanoparticles for Cancer Therapy
Zhou, Z., Song, J., Tian, R., Yáng, Z., Yu, G., Lin, L., Zhang, G., Fan, W., Zhang, F., Niu, G., et al. (2017) · Angewandte Chemie · doi:10.1002/ange.201701181 · Cited by 84
Pandey, N. K., Chudal, L., Phan, J. B., Lin, L., Johnson, O., Xing, M., Liu, J. P., Li, H., Huang, X., Shu, Y., et al. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01566c · Cited by 84
Xu, X., Liu, K., Jiao, B., Luo, K., Ren, J. M., Zhang, G., Yu, Q., & Gan, Z. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.03.028 · Cited by 84
miRNAs, oxidative stress, and cancer: A comprehensive and updated review
Ebrahimi, S. O., Reiisi, S., & Shareef, S. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29724 · Cited by 91
In situ fabrication of MS@MnO 2 hybrid as nanozymes for enhancing ROS-mediated breast cancer therapy
Zhu, X., Liu, Y., Yuan, G., Guo, X., Cen, J., Gong, Y., Liu, J., & Ye, G. (2020) · Nanoscale · doi:10.1039/d0nr03931d · Cited by 86
Targeting Cancer Cell Mitochondria as a Therapeutic Approach: Recent Updates
Cui, Q., Wen, S., & Huang, P. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0011 · Cited by 87
Self-citationInteractions between epigenetics and metabolism in cancers
Yun, J., Johnson, J. L., Hanigan, C. L., & Locasale, J. W. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00163 · Cited by 82
“Rapid cell proliferation, as seen in cancers, often results in the overproduction of reactive oxygen species (ROS) (Trachootham et al., 2009).”
BackgroundInfluentialModelling the helium plasma jet delivery of reactive species into a 3D cancer tumour
Szili, E. J., Oh, J., Fukuhara, H., Bhatia, R., Gaur, N., Nguyen, C. K., Hong, S., Ito, S., Ogawa, K., Kawada, C., et al. (2017) · Plasma Sources Science and Technology · doi:10.1088/1361-6595/aa9b3b · Cited by 88
“supposedly making the cells more vulnerable to oxidative damage [122, 123], and (3) owing to their proliferative nature,”
BackgroundQi, R., Wang, Y., Bruno, P. M., Xiao, H., Yu, Y., Li, T., Lauffer, S., Wei, W., Chen, Q., Kang, X., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02390-7 · Cited by 83
Facile synthesis of Cu-CuFe 2 O 4 nanozymes for sensitive assay of H 2 O 2 and GSH
Xia, F., Shi, Q., & Nan, Z. (2020) · Dalton Transactions · doi:10.1039/d0dt02395g · Cited by 85
Tumor Microenvironment Sensitive Nanocarriers for Bioimaging and Therapeutics
Park, H., Saravanakumar, G., Kim, J., Lim, J., & Kim, W. J. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000834 · Cited by 88
Malhi, S. S., Budhiraja, A., Arora, S., Chaudhari, K. R., Nepali, K., Kumar, R., Sohi, H., & Murthy, R. S. R. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.04.030 · Cited by 82
Arseneault, R., Chien, A., Newington, J. T., Rappon, T., Harris, R. A., & Cumming, R. C. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.03.034 · Cited by 85
Metabolism pathways in chronic lymphocytic leukemia
Rozovski, U., Hazan‐Halevy, I., Barzilai, M., Keating, M. J., & Estrov, Z. E. (2015) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2015.1106533 · Cited by 92
“signaling [37], genetic instability [38] and cancer cell”
BackgroundChang, K., Hsu, T., Hsu, C.-C., Tsai, S.-Y., Liu, J.-J., Chou, S.-W., Liu, M.-S., Liou, J., Ko, C., Chen, K., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.08.005 · Cited by 82
“Under certain circumstances, tumors have been shown to upregulate antioxidant enzyme expression to promote survival and resistance to certain anticancer agents [12].”
BackgroundKhan, F., Khan, I., Farooqui, A., & Ansari, I. A. (2017) · Nutrition and Cancer · doi:10.1080/01635581.2017.1359321 · Cited by 82
“However, the induction of ROS formation plays an important role in the chemotherapeutic activity of several anticancer drugs and a large number of anticancer compounds (52,53).”
BackgroundPandey, P., Sayyed, U., Tiwari, R. K., Siddiqui, M. H., Pathak, N., & Bajpai, P. (2018) · Nutrition and Cancer · doi:10.1080/01635581.2018.1508732 · Cited by 82
“Loss of MMP leads to caspase-3 activation with a subsequent loss in cell proliferation (29).”
BackgroundBioactivation of Napabucasin Triggers Reactive Oxygen Species–Mediated Cancer Cell Death
Froeling, F. E. M., Swamynathan, M. M., Deschênes, A., Chio, I. I. C., Brosnan, E., Yao, M. A., Alagesan, P., Lucito, M. S., Li, J., Chang, A., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0302 · Cited by 88
“In addition, ROS can either inhibit or activate protein function through altering their phosphorylation status via thiol oxidation of either tyrosine phosphatases or kinases (1, 38, 39).”
BackgroundCheng, G., Zielonka, J., McAllister, D. M., Hardy, M., Ouari, O., Joseph, J., Dwinell, M. B., & Kalyanaraman, B. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.05.016 · Cited by 82
Promising anti‐tumor properties of bisdemethoxycurcumin: A naturally occurring curcumin analogue
Ramezani, M., Hatamipour, M., & Sahebkar, A. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25795 · Cited by 82
Wada, F., Koga, H., Akiba, J., Niizeki, T., Iwamoto, H., Ikezono, Y., Nakamura, T., Abe, M., Masuda, A., Sakaue, T., et al. (2018) · Cancer Science · doi:10.1111/cas.13728 · Cited by 81
“Such binding stabilizes expression of this transporter system at the cell surface and thereby promotes intracellular synthesis of the antioxidant glutathione (GSH) from incorporated cysteine.(15) Thus, expression of CD44v9 in tumor cells confers resistance to oxidative stress and promotes tumor growth and resistance t…”
BackgroundThe Role of Ceramide Metabolism and Signaling in the Regulation of Mitophagy and Cancer Therapy
Sheridan, M., & Öğretmen, B. (2021) · Cancers · doi:10.3390/cancers13102475 · Cited by 89
Zhang, Z., Pan, Y., Cun, J., Li, J., Guo, Z., Pan, Q., Gao, W., Pu, Y., Luo, K., & He, B. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.07.055 · Cited by 83
Stimuli‐Responsive Nanotechnology for RNA Delivery
Zhou, H., Chen, D. S., Hu, C. J., Hong, X., Shi, J., & Xiao, Y. (2023) · Advanced Science · doi:10.1002/advs.202303597 · Cited by 96
Cabello, C. M., Lamore, S. D., Bair, W. B., Qiao, S., Azimian, S., Lesson, J. L., & Wondrak, G. T. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9676-7 · Cited by 82
“darinaparsin, arsenic trioxide, NOV-002, PX-12, disulfiram, and elesclomol as recently reviewed [1, 10, 11].”
Raja, S. M., Clubb, R. J., Ortega-Cava, C. F., Williams, S. H., Bailey, T. A., Duan, L., Zhao, X., Reddi, A. L., Nyong, A. M., Natarajan, A., et al. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.2.13959 · Cited by 86
“Given the importance of the Michael acceptor functionality for the biological activity of Celastrol, and the propensity of this group to covalently react with cellular free thiols (on reduced Glutathione and redoxbalancing enzymes),(26) we asked if higher Celastrol sensitivity of ErbB2-overexpressing breast cancer cel…”
BackgroundMa, P., Yan, B., Zeng, Q., Liu, X., Wu, Y., Jiao, M., Liu, C., Wu, J., & Yang, X. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.03.027 · Cited by 86
Wang, X., Li, X., Liang, X., Liang, J., Zhang, C., Yang, J., Wang, C., Kong, D., & Sun, H. (2018) · Journal of Materials Chemistry B · doi:10.1039/c7tb02688a · Cited by 86
Targeting Cancer Stem Cell Redox Metabolism to Enhance Therapy Responses
Luo, M., & Wicha, M. S. (2018) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2018.10.003 · Cited by 81
“Many chemotherapeutic agents or ionizing radiation, by inducing oxidative stress, are able to elicit ROS-mediated cytotoxicity in bulk tumor cells which are more susceptible to second oxidative insults compared to their normal counterparts [31, 32].”
BackgroundA Metabolism Toolbox for CAR T Therapy
Xu, X., Gnanaprakasam, J. N. R., Sherman, J., & Wang, R. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00322 · Cited by 83
Das, T. P., Suman, S., & Damodaran, C. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22014 · Cited by 85
Augment of Oxidative Damage with Enhanced Photodynamic Process and MTH1 Inhibition for Tumor Therapy
Hu, J., Chen, Y., Li, Z.-H., Peng, S., Sun, Y., & Zhang, X. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b02112 · Cited by 80
Sklias, K., Sousa, J. S., & Girard, P.-M. (2021) · Cancers · doi:10.3390/cancers13040615 · Cited by 83
Yuan, X., Wang, L., Hu, M., Zhang, L., Chen, H., Zhang, D., Wang, Z., Li, T., Zhong, M., Xu, L., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202107556 · Cited by 82
Urchin-like ceria nanoparticles for enhanced gene therapy of osteoarthritis
Chen, H., Tianwen, Y., Hu, F., Chen, K., Li, B., Qiu, M., Chen, Z., Sun, Y., Ye, W., Wang, H., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf0988 · Cited by 90
“ROS mainly include superoxide anion, H 2 O 2 , and hydroxyl radicals ( 38 ).”
Ambrož, M., Boušová, I., Skarka, A., Hanušová, V., Králová, V., Matoušková, P., Szotáková, B., & Skálová, L. (2015) · Molecules · doi:10.3390/molecules200815343 · Cited by 80
“, [36,37]).”
Chaib, H., Nebbioso, A., Prébet, T., Castellano, R., Garbit, S., Restouin, A., Vey, N., Altucci, L., & Collette, Y. (2011) · Leukemia · doi:10.1038/leu.2011.271 · Cited by 88
DNA damage in oral cancer cells induced by nitrogen atmospheric pressure plasma jets
Han, X., Klas, M., Liu, Y., Stack, M. S., & Ptasińska, S. (2013) · Applied Physics Letters · doi:10.1063/1.4809830 · Cited by 80
Oleksiewicz, U., Liloglou, T., Field, J. K., & Xinarianos, G. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0764-9 · Cited by 89
“Stress-related adaptive machinery in cancer frequently corresponds to modulation of signalling pathways that control cell survival, apoptosis, angiogenesis and resistance to chemo- and radiotherapy [129].”
BackgroundSense and Sensitivity: FOXO and ROS in Cancer Development and Treatment
Myatt, S. S., Brosens, J. J., & Lam, E. W. ‐. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3383 · Cited by 83
“This is because oncogenic transformation elevates ROS to such high levels that a further acute increase triggers reactivation of the apoptotic program in cancer cells (95).”
Influential
Metadata
- Authors
- Trachootham, D., Alexandre, J., & Huang, P.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Huang, Peng
- Venue
- Nature Reviews Drug Discovery
- Published
- 2009-05-29
- Volume
- 8
- Issue
- 7
- Pages
- 579-591
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1972779889
- Cited by
- 5,452
- References
- 163
- Citations by year
- 2026: 322 · 2025: 332 · 2024: 340 · 2023: 372 · 2022: 421 · 2021: 462 · 2020: 444 · 2019: 454 · 2018: 393 · 2017: 404 · 2016: 341 · 2015: 289 · 2014: 282 · 2013: 204 · 2012: 158
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA085563, R01CA109041, CA109041, R01CA085563, R01CA100428, CA100428)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Keywords
- reactive oxygen species, oxidative stress, redox modulation, cancer cells, drug resistance, antioxidant capacity, anticancer agents, genomic instability
- MeSH terms
- Adaptation, Physiological, Animals, Glutathione, Humans, Neoplasms, Oxidation-Reduction, Neoplastic Stem Cells, Reactive Oxygen Species, Drug Resistance, Neoplasm
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.